Fraunhofer Institute for Toxicology and Experimental Medicine

Fraunhofer consortium to jointly develop therapies and platform technologies against COVID-19 and other infectious diseases.

Identification of drugs against COVID-19 and development of therapies.

Disseminated breast cancer cells use bone marrow growth factors for metastasis formation.

Quantitative targeted metabolomics, with a focus on a subset of hundreds of metabolites, is a valuable tool to study possible underlying mechanisms.

New publication by Christoph A. Klein: „Cancer progression and the invisible phase of metastatic colonization”.

Fraunhofer innovation cluster relies on automation technologies in medical research.

Research at Fraunhofer ITEM is focused on human health – and this has been so for almost four decades.

The emphasis is on two aspects: firstly, on protecting health from potentially harmful, in particular airborne substances, be they gases, aerosols, particles, fibers, or nanomaterials, and secondly, on investigating and developing diagnostic and therapeutic approaches, both at the preclinical and clinical levels.

A special focus is on airway research.